Genetics

Multiple sclerosis (MS) is a complex neurological disorder characterized by substantial variability in both disease onset and long-term progression. Recent advances in genomic research have revealed that the genetic factors influencing the risk of developing MS may differ from those that determine how severe the disease becomes. This blog post explores the evolving understanding of MS genetics, highlighting key discoveries from genome-wide association studies, the prominent role of immune-related genes such as HLA-DRB11501*, and newly identified variants associated with disease severity. By examining the distinction between immune-driven susceptibility and neurodegeneration-related progression, the discussion sheds light on how genetic research is shaping the future of precision medicine and personalized treatment strategies in multiple sclerosis.